Literature DB >> 10217093

Liposuction for protease-inhibitor-associated lipodystrophy.

S Ponce-de-Leon, M Iglesias, J Ceballos, L Ostrosky-Zeichner.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10217093     DOI： 10.1016/S0140-6736(99)01172-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  HIV-associated lipodystrophy syndrome: A review of clinical aspects.

Authors:  Jean-Guy Baril; Patrice Junod; Roger Leblanc; Harold Dion; Rachel Therrien; Franãois Laplante; Julian Falutz; Pierre Côté; Marie-Nicole Hébert; Richard Lalonde; Normand Lapointe; Dominic Lévesque; Lyse Pinault; Danielle Rouleau; Cécile Tremblay; Benoãt Trottier; Sylvie Trottier; Chris Tsoukas; Karl Weiss
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

Review 2.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

Review 3.  Lipodystrophy syndrome in patients with HIV infection: quality of life issues.

Authors:  E Martínez; M A Garcia-Viejo; L Blanch; J M Gatell
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 4.  Adverse effects of antiretroviral therapy for HIV infection.

Authors:  Valentina Montessori; Natasha Press; Marianne Harris; Linda Akagi; Julio S G Montaner
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262

Review 5.  Evaluation and management of dyslipidemia in patients with HIV infection.

Authors:  Michael L Green
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.